Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants

Journal of Pediatrics

Volumn 143, Issue 2, 2003, Pages 199-202

  Lassus, Patrik ^a,b   Heikkilä, Päivi ^a   Andersson, Leif C ^a   Von Boguslawski, Kristina ^a   Andersson, Sture ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; IMMUNOGLOBULIN A; LUNG SURFACTANT EXTRACT; SCATTER FACTOR;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG DEVELOPMENT; LUNG DISEASE; LUNG DYSPLASIA; LUNG INJURY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0042333350     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00297-X     Document Type: Article

References (25)

1. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 1992;90:663-8.
2. Stevenson DK, Wright LL, Lemons JA, William OH, Korones SB, Papile L-A, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1994;179:1632-9.
3. Margraf LR, Tomashefski JF Jr, Bruce MC, Dahms BB. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991;143:391-400.
4. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-7.
5. Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 2000;47:606-13.
6. Jobe AH. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3.
7. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987;327:239-42.
8. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-3.
9. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor the c-Met tyrosine kinase. Trends Cell Biol 1998;8:404-10.
10. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-4.
11. Itakura A, Kurauchi O, Morikawa S, Okamura M, Furugori K, Mizutani S. Involvement of hepatocyte growth factor in formation of bronchoalveolar structures in embryonic rat lung in primary culture. Biochem Biophys Res Commun 1997;241:98-103.
12. Kagoshima M, Kinoshita T, Matsumoto K, Nakamura T. Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung. Eur J Biochem 1992;210:375-80.
13. Ohmichi H, Koshimizu U, Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 1998;125:1315-24.
14. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993;268:21212-7.
15. Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury: biologic and clinical significance. Am J Respir Crit Care Med 1998;158:386-94.
16. Panos RJ, Patel R, Bak PM. Intratracheal administration of hepatocyte growth factor/scatter factor stimulates rat alveolar type II cell proliferation in vivo. Am J Respir Cell Mol Biol 1996;15:574-81.
17. Ohmichi H, Matsumoto K, Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration. Am J Physiol 1996;270:L1031-39.
18. Sakamaki Y, Matsumoto K, Mizuno S, Miyoshi S, Matsuda H, Nakamura T. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol 2002;26:525-33.
19. Lassus P, Nupponen I, Kari A, Pohjavuori M, Andersson S. The effect of dexamethasone on hepatocyte growth factor and vascular endothelial growth factor in human preterm lung. Pediatrics 2002;110:768-71.
20. Haschek WM, Witschi H. Pulmonary fibrosis: a possible mechanism. Toxicol Appl Pharmacol 1979;51:475-87.
21. Adamson IYR, Bakowska J. Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin. Am J Pathol 1999;155:949-54.
22. Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin: a morphologic study. Am J Respir Crit Care Med 1997;156:1937-44.
23. Mason RJ. Hepatocyte growth factor: the key to alveolar septation? Am J Respir Cell Mol Biol 2002;26:517-20.
24. Stern J-B, Fierobe L, Paugam C, Rolland C, Dehoux M, Petiet A, et al. Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients. Crit Care Med 2000;28:2326-33.
25. Vivekananda J, Awasthi V, Awasthi S, Smith DB, King RJ. Hepatocyte growth factor is elevated in chronic lung injury and inhibits surfactant metabolism. Am J Physiol Lung Cell Mol Physiol 2000;278:L382-92.